Described are proteins and immunogenic compositions for preventing infection with influenza viruses wherein the immunogenic compositions comprises immunogens such as the M2e and HA2 FP domains of influenza A virus and an immunopotentiator such as an Fc fragment of human IgG and optionally a stabilization sequence.